文献速递肝病消化道肿瘤与早癌

乙肝病毒整合TERT启动子通过宿主ELF4激活端粒酶逆转录酶转录

Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2020-11-26

该研究采用靶向测序策略调查95例乙肝病毒相关肝细胞癌的HBV整合,发现TERT启动子整合频繁(35.8%,34/95),与TERT mRNA表达升高及侵袭性肿瘤行为相关。机制上,HBV增强子I是关键病毒组分,宿主转录因子ELF4结合整合形成的嵌合增强子I,反式激活TERT转录,促进肝癌发生。

要点

  • HBV整合TERT启动子在乙肝相关肝癌中发生率为35.8%(34/95)。
  • 整合与TERT mRNA表达升高及更具侵袭性的肿瘤行为相关。
  • HBV增强子I和宿主ELF4是TERT反式激活的关键分子机制。

核心结论

  • HBV整合TERT启动子通过宿主ELF4结合病毒增强子I反式激活TERT转录,促进肝癌发生。

研究设计与样本

  • 采用靶向测序策略调查95例人HBV相关肝细胞癌的HBV整合。
  • 使用荧光素酶报告基因构建体、小干扰RNA文库功能筛选及细胞系实验验证机制。

主要发现

  • TERT启动子HBV整合在肝癌中频繁发生(35.8%,34/95),与TERT mRNA表达升高及侵袭性肿瘤行为相关。
  • HBV增强子I是整合后激活TERT的关键病毒组分。
  • HBV整合方向进一步调节TERT转录激活程度。
  • ELF4结合TERT启动子处的嵌合HBV增强子I,导致端粒酶激活。
  • 稳定敲低ELF4显著降低肝癌细胞TERT表达和成球能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Hepatitis B virus (HBV) integrations are common in hepatocellular carcinoma (HCC). In particular, alterations of the telomerase reverse transcriptase (TERT) gene by HBV integrations are frequent; however, the molecular mechanism and functional consequence underlying TERT HBV integration are unclear. APPROACH AND RESULTS: We adopted a targeted sequencing strategy to survey HBV integrations in human HBV-associated HCCs (n = 95). HBV integration at the TERT promoter was frequent (35.8%, n = 34/95) in HCC tumors and was associated with increased TERT mRNA expression and more aggressive tumor behavior. To investigate the functional importance of various integrated HBV components, we employed different luciferase reporter constructs and found that HBV enhancer I (EnhI) was the key viral component leading to TERT activation on integration at the TERT promoter. In addition, the orientation of the HBV integration at the TERT promoter further modulated the degree of TERT transcription activation in HCC cell lines and patients' HCCs. Furthermore, we performed array-based small interfering RNA library functional screening to interrogate the potential major transcription factors that physically interacted with HBV and investigated the cis-activation of host TERT gene transcription on viral integration. We identified a molecular mechanism of TERT activation through the E74 like ETS transcription factor 4 (ELF4), which normally could drive HBV gene transcription. ELF4 bound to the chimeric HBV EnhI at the TERT promoter, resulting in telomerase activation. Stable knockdown of ELF4 significantly reduced the TERT expression and sphere-forming ability in HCC cells. CONCLUSIONS: Our results reveal a cis-activating mechanism harnessing host ELF4 and HBV integrated at the TERT promoter and uncover how TERT HBV-integrated HCCs may achieve TERT activation in hepatocarcinogenesis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sze KM, Ho DW, Chiu YT, et al. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma. Hepatology. 2020. PMID: 32170761. doi:10.1002/hep.31231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。